| 000 | 01921 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517100154.0 | ||
| 264 | 0 | _c20170302 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1473-5628 | ||
| 024 | 7 |
_a10.1097/MNM.0000000000000547 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThapa, Pradeep | |
| 245 | 0 | 0 |
_aPerformance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics. _h[electronic resource] |
| 260 |
_bNuclear medicine communications _cOct 2016 |
||
| 300 |
_a1030-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCell Proliferation _xradiation effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeuroendocrine Tumors _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOctreotide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
| 650 | 0 | 4 | _aRadioactive Tracers |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xmetabolism |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRanade, Rohit | |
| 700 | 1 | _aOstwal, Vikas | |
| 700 | 1 | _aShrikhande, Shailesh V | |
| 700 | 1 | _aGoel, Mahesh | |
| 700 | 1 | _aBasu, Sandip | |
| 773 | 0 |
_tNuclear medicine communications _gvol. 37 _gno. 10 _gp. 1030-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MNM.0000000000000547 _zAvailable from publisher's website |
| 999 |
_c26075301 _d26075301 |
||